Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
R. Somers
Sign up to set email alerts
38
Publications
1,830
Citation Statements Received
52
Citation Statements Given
How they've been cited
3,564
70
1,746
14
How they cite others
499
3
49
0
Affiliations
The Netherlands Cancer Institute
,
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Publications
Order By: Most citations
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
Graux
1
,
Cools
2
,
Melotte
3
et al.
2004
Nat Genet
415
14
339
1
Get access via publisher
Add to collection
Cite
Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
Van Glabbeke
1
,
van Oosterom
2
,
Oosterhuis
3
et al.
1999
JCO
Abstract
Show
569
22
319
7
Get access via publisher
Add to collection
Cite
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Santoro
1
,
Tursz
2
,
Mouridsen
3
et al.
1995
JCO
Abstract
Show
516
5
287
1
Get access via publisher
Add to collection
Cite
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
Bramwell
1
,
Burgers
2
,
Sneath
3
et al.
1992
JCO
Abstract
Show
323
8
187
1
Get access via publisher
Add to collection
Cite
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
Tirelli
1
,
Errante
2
,
Van Glabbeke
3
et al.
1998
JCO
Abstract
Show
209
3
78
1
Get access via publisher
Add to collection
Cite
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Teodorović
1
,
Pittaluga
2
,
Kluin‐Nelemans
3
et al.
1995
JCO
Abstract
Show
153
3
75
1
Get access via publisher
Add to collection
Cite
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Steward
1
,
Verweij
2
,
Somers
3
et al.
1993
JCO
Abstract
Show
153
0
58
0
Get access via publisher
Add to collection
Cite
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach
Taal
1
,
Burgers
2
,
van Heerde
3
et al.
1993
Annals of Oncology
Abstract
Show
97
2
43
1
Get access via publisher
Add to collection
Cite
1
2
3
4
5